Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TEMBO GLOBAL - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TEMBO GLOBAL NOVARTIS/
TEMBO GLOBAL
 
P/E (TTM) x 86.1 - - View Chart
P/BV x 2.7 12.0 22.4% View Chart
Dividend Yield % 1.3 0.4 360.1%  

Financials

 NOVARTIS   TEMBO GLOBAL
EQUITY SHARE DATA
    NOVARTIS
Mar-21
TEMBO GLOBAL
Mar-21
NOVARTIS/
TEMBO GLOBAL
5-Yr Chart
Click to enlarge
High Rs770NA-   
Low Rs501NA-   
Sales per share (Unadj.) Rs154.5104.8 147.4%  
Earnings per share (Unadj.) Rs8.52.9 296.7%  
Cash flow per share (Unadj.) Rs13.44.2 315.9%  
Dividends per share (Unadj.) Rs10.001.00 1,000.0%  
Avg Dividend yield %1.6NM- 
Book value per share (Unadj.) Rs289.223.3 1,242.5%  
Shares outstanding (eoy) m24.6910.05 245.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.10-   
Avg P/E ratio x75.10-  
P/CF ratio (eoy) x47.50-  
Price / Book Value ratio x2.20-  
Dividend payout %118.135.0 337.2%   
Avg Mkt Cap Rs m15,6910-   
No. of employees `000NANA-   
Total wages/salary Rs m1,08523 4,629.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,8141,053 362.1%  
Other income Rs m3321 27,899.2%   
Total revenues Rs m4,1461,054 393.2%   
Gross profit Rs m26780 331.5%  
Depreciation Rs m12214 872.9%   
Interest Rs m7727 280.6%   
Profit before tax Rs m40040 991.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m19112 1,635.9%   
Profit after tax Rs m20929 729.0%  
Gross profit margin %7.07.6 91.6%  
Effective tax rate %47.829.0 164.9%   
Net profit margin %5.52.7 201.3%  
BALANCE SHEET DATA
Current assets Rs m9,224619 1,490.8%   
Current liabilities Rs m3,573412 867.7%   
Net working cap to sales %148.219.7 754.0%  
Current ratio x2.61.5 171.8%  
Inventory Days Days1761 11,809.0%  
Debtors Days Days37109,083,856 0.0%  
Net fixed assets Rs m2,480184 1,345.9%   
Share capital Rs m123100 122.8%   
"Free" reserves Rs m7,018134 5,256.9%   
Net worth Rs m7,141234 3,052.4%   
Long term debt Rs m0161 0.0%   
Total assets Rs m11,703806 1,452.6%  
Interest coverage x6.22.5 251.1%   
Debt to equity ratio x00.7 0.0%  
Sales to assets ratio x0.31.3 24.9%   
Return on assets %2.47.0 35.1%  
Return on equity %2.912.3 23.9%  
Return on capital %6.717.1 39.0%  
Exports to sales %9.352.1 17.8%   
Imports to sales %01.2 0.0%   
Exports (fob) Rs m354549 64.4%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m354549 64.4%   
Fx outflow Rs m97419 5,076.9%   
Net fx Rs m-621529 -117.2%   
CASH FLOW
From Operations Rs m-692-42 1,637.3%  
From Investments Rs m952-121 -788.7%  
From Financial Activity Rs m-368167 -221.0%  
Net Cashflow Rs m-1094 -3,030.7%  

Share Holding

Indian Promoters % 0.0 72.8 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 2.2 36.2%  
FIIs % 0.0 2.2 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 27.2 107.6%  
Shareholders   45,141 1,206 3,743.0%  
Pledged promoter(s) holding % 0.0 8.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   HCL INFOSYS    MMTC    SUNDRAM FASTENERS    FUTURE CONSUMER    STC INDIA    



Today's Market

Sensex Trades in Green as Automobile Stocks Rally; HCL Tech Dips 6% Post Q3 Results(10:30 am)

Asian stock markets are trading on a mixed note today ahead of data expected to underline China's economic slowdown, as traders weighed policy easing by the nation's central bank.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022(Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jan 17, 2022 12:15 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - ZUARI GLOBAL COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS